AstraZeneca Aktie
124,00
EUR
-1,75
EUR
-1,39
%
118,31
CHF
-3,34
CHF
-2,74
%
Kursziele der AstraZeneca-Aktie in GBP
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 110,00 GBP | - | 04.06.2025 | |
| JP Morgan Chase & Co. | 140,00 GBP | - | 03.06.2025 | |
| UBS AG | 142,00 GBP | - | 03.06.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 140,00 GBP | - | 16.05.2025 | |
| Goldman Sachs Group Inc. | 144,82 GBP | - | 01.05.2025 | |
| DZ BANK | - | - | 30.04.2025 | |
| Jefferies & Company Inc. | 109,00 GBP | - | 29.04.2025 | |
| Bernstein Research | 172,00 GBP | - | 29.04.2025 | |
| Barclays Capital | 135,00 GBP | - | 24.06.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | - |
| Bayer | 2 | 7 | 0 | 26,00 EUR | -3,76% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +28,92% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 2 | 0 | - | - |
| EVOTEC SE | 2 | 3 | 0 | 9,96 EUR | +41,72% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 165,86 EUR | +47,37% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +163,52% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +4,37% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +21,54% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 279,75 CHF | +6,94% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 116,12 EUR | +36,55% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |